The FDA just fast-tracked psychedelic drugs to treat depression. They could be here by this summer
Summary
The FDA issued priority vouchers for three experimental new drugs using psilocybin and methylone, amid Trump's pro-psychedelics push.
Description
The FDA issued priority vouchers for three experimental new drugs using psilocybin and methylone, amid Trump's pro-psychedelics push.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source